Tailoring the approach to multimorbidity in adults with respiratory disease: the NICE guideline

The National Institute for Health and Care Excellence (NICE) previously published guidelines for the management of individual diseases [1]. However, elderly patients commonly suffer from two or more chronic diseases [2]. Multimorbidity is associated with a high treatment and care burden that may impact on the wellbeing of the patient http://ow.ly/D0xM307Ttoe

[1]  E. Wouters,et al.  A new perspective on COPD exacerbations: monitoring impact by measuring physical, psychological and social resilience , 2016, European Respiratory Journal.

[2]  U. Kadam,et al.  Multi-drug therapy in chronic condition multimorbidity: a systematic review. , 2014, Family practice.

[3]  M. Wehling.  MULTIMORBIDITY AND POLYPHARMACY: HOW TO REDUCE THE HARMFUL DRUG LOAD AND YET ADD NEEDED DRUGS IN THE ELDERLY? PROPOSAL OF A NEW DRUG CLASSIFICATION: FIT FOR THE AGED , 2009, Journal of the American Geriatrics Society.

[4]  J. Gold,et al.  Validation of a combined comorbidity index. , 1994, Journal of clinical epidemiology.

[5]  F. Martinez,et al.  Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. , 2007, American journal of respiratory and critical care medicine.

[6]  E. Wouters,et al.  Poor agreement between chart-based and objectively identified comorbidities of COPD , 2015, European Respiratory Journal.

[7]  S. Kon,et al.  Physical frailty and pulmonary rehabilitation in COPD: a prospective cohort study , 2016, Thorax.

[8]  Ciro Casanova,et al.  The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. , 2004, The New England journal of medicine.

[9]  E. Wouters,et al.  Management of chronic obstructive pulmonary disease beyond the lungs. , 2016, The Lancet. Respiratory medicine.

[10]  M. Decramer,et al.  Withdrawal of inhaled glucocorticoids and exacerbations of COPD. , 2014, The New England journal of medicine.

[11]  A. Wu,et al.  Clinical practice guidelines and quality of care for older patients with multiple comorbid diseases: implications for pay for performance. , 2005, JAMA.

[12]  E. Wouters,et al.  Determinants of polypharmacy and compliance with GOLD guidelines in patients with chronic obstructive pulmonary disease , 2011, International journal of chronic obstructive pulmonary disease.

[13]  B. Starfield,et al.  Prevalence, expenditures, and complications of multiple chronic conditions in the elderly. , 2002, Archives of internal medicine.

[14]  Martijn A Spruit,et al.  Integration of pulmonary rehabilitation in COPD , 2008, The Lancet.

[15]  S. Wyke,et al.  Epidemiology of multimorbidity and implications for health care, research, and medical education: a cross-sectional study , 2012, The Lancet.

[16]  Richard B. Reilly,et al.  Objective Assessment of Adherence to Inhalers by Patients with Chronic Obstructive Pulmonary Disease , 2017, American journal of respiratory and critical care medicine.

[17]  Martin Fortin,et al.  Comparative assessment of three different indices of multimorbidity for studies on health-related quality of life , 2005, Health and quality of life outcomes.

[18]  Ioanna Chouvarda,et al.  WELCOME — Innovative integrated care platform using wearable sensing and smart cloud computing for COPD patients with Comorbidities , 2014, 2014 36th Annual International Conference of the IEEE Engineering in Medicine and Biology Society.

[19]  J. Walters,et al.  Systemic corticosteroids in chronic obstructive pulmonary disease: an overview of Cochrane systematic reviews. , 2007, Respiratory medicine.

[20]  B. Celli,et al.  Comorbidities and risk of mortality in patients with chronic obstructive pulmonary disease. , 2012, American journal of respiratory and critical care medicine.

[21]  J. Seheult,et al.  Objective Assessment of Adherence to Inhalers by COPD Patients , 2019, Case Medical Research.

[22]  Martijn A Spruit,et al.  Clusters of comorbidities based on validated objective measurements and systemic inflammation in patients with chronic obstructive pulmonary disease. , 2013, American journal of respiratory and critical care medicine.